Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.
Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.